Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Amortizatization of Intangibles (2017 - 2025)

Avalo Therapeutics filings provide 7 years of Amortizatization of Intangibles readings, the most recent being $197000.0 for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles changed N/A to $197000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $544000.0, a N/A change, with the full-year FY2025 number at $690000.0, changed N/A from a year prior.
  • Amortizatization of Intangibles hit $197000.0 in Q4 2025 for Avalo Therapeutics, down from $347000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $900000.0 in Q3 2023 to a low of $104000.0 in Q2 2021.
  • Median Amortizatization of Intangibles over the past 4 years was $349000.0 (2021), compared with a mean of $360500.0.
  • The widest YoY moves for Amortizatization of Intangibles: up 223.08% in 2022, down 0.0% in 2022.
  • Avalo Therapeutics' Amortizatization of Intangibles stood at $349000.0 in 2021, then changed by 0.0% to $349000.0 in 2022, then surged by 157.88% to $900000.0 in 2023, then plummeted by 78.11% to $197000.0 in 2025.
  • The last three reported values for Amortizatization of Intangibles were $197000.0 (Q4 2025), $347000.0 (Q3 2025), and $900000.0 (Q3 2023) per Business Quant data.